Pfizer

Now entering late-stage clinical trials, the vaccine could be approved as soon as 2025.

The Pfizer pill, Paxlovid, is intended for people with COVID-19 who are more likely to become seriously ill. Previously only doctors could prescribe the drug

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

Alyssa Allen and her family of four have waited patiently for this moment. The FDA began to green-light the COVID-19 vaccine for infants, toddlers and children five and under. Allen’s daughter Hallie is 3 years old, the only one in the family not protected. “The big word is ‘finally,’ my family has been waiting what feels like forever to get…

NBC 6’s Marissa Bagg has details on the FDA panel vote authorizing vaccines for kids under 5 and the next step that follows

The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season. The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island. The site will provide patients with immediate access to the drug once they test positive....

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries. That includes its top-selling COVID-19 vaccine and treatment. The pharmaceutical giant said early Wednesday that it is launching a program aimed at improving health equity in 45 lower-income countries. Most of those nations are in Africa. The drugmaker aims to provide...

Pfizer says it will seek emergency use authorization for a three-dose course of its COVID-19 vaccine in pediatric patients ages 6 months to 5 years old after publishing data from it’s latest study.

The 18 million kids under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.

The center’s director, Dr. Rochelle Walensky, adopted a panel’s recommendation Thursday.

Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June.

President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed

Pfizer and its partner BioNTech said Thursday new data shows its kid-sized booster shot helps healthy 5- to 11-year-olds rev up virus-fighting antibodies.

Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill

Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors

However, the Pfizer shots still offered protection against serious illness from COVID, the researchers found.